Michalina Chodór

Michalina Chodór

Auto-generated profile, based on publicly available information

Michalina Chodór

Medical University of Silesia in Katowice, Katowice, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MKMaciej Kokoszka
Maciej Kokoszka
MCMichalina Chodór
Michalina Chodór
JKJulia Maria Kuczkowska
Julia Maria Kuczkowska
JBJudyta Bordakiewicz
Judyta Bordakiewicz
ZMZuzanna Michalska
Zuzanna Michalska
MWMagdalena Wiciak
Magdalena Wiciak
Introduction: Contemporary medicine is undergoing an unprecedented transformation driven by the integration of advanced artificial intelligence (AI) and large language models (LLMs) into clinical workflows. While these technologies objectively enhance diagnostic precision, their implementation creates a fundamental paradox: the increase in technological efficacy often correlates with a decline in patient trust, known as the "AI trust gap." This review examines the tension between algorithmic authority and the necessity of the "human touch," analyzing the impact of digital innovations on clinical autonomy and the patient-physician-AI triad. Materials and Methods: This study presents a detailed analysis of 44 peer-reviewed scientific articles published between 2022 and 2026. The review focuses on Clinical Decision Support Systems (CDSS) across key diagnostic areas, including radiology and pathology. The analysis encompasses the psychological mechanisms of AI acceptance, the risks of automation bias, and the potential of Explainable AI (XAI) to restore clinical transparency. Key Findings: Research reveals that the mere disclosure of AI involvement can reduce patient trust (dropping from 0.50 to 0.30–0.34 in experimental settings). A "paradox of knowledge" was identified, where higher patient literacy regarding AI correlates with increased skepticism. Regarding clinical autonomy, a dichotomy exists: junior clinicians are prone to automation bias, while experts face the risk of "deskilling." The review also discusses the "Algorithmic Consultant" role and the necessity of "Triadic Decision-Making," where AI serves as a transparent partner rather than a black-box authority. Conclusions: The integration of AI requires a reconfiguration of medical practice from a technology-first approach to a human-centered design. Preserving clinical autonomy depends on adopting a "trust but verify" model and implementing XAI strategies to mitigate transparency barriers. The success of algorithmic medicine relies on maintaining the physician's judgment as the cornerstone of care, ensuring that AI functions as a supportive co-pilot.

29 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
MCMichalina Chodór
Michalina Chodór
MKMaciej Kokoszka
Maciej Kokoszka
NNNatalia Nafalska
Natalia Nafalska
MSMałgorzata Stopyra
Małgorzata Stopyra
KFKrzysztof Feret
Krzysztof Feret
AAAgata Paulina Andrzejczyk
Agata Paulina Andrzejczyk
Background: Spices like capsaicin, turmeric, ginger, piperine, garlic, and cinnamon have been used in cooking and folk medicine for centuries. Modern research shows their ergogenic, anti-inflammatory, and antioxidant properties, aiding athletic performance, muscle recovery, and overall health. Aim: This review analyzes effects of these spices on physically active individuals (mechanisms, benefits, limitations). Materials and methods: Studies from PubMed, MDPI, Quality in Sport, and Journal of Pharmaceutical Research International on ergogenic, anti-inflammatory, and antioxidant effects of capsaicin, turmeric, ginger, piperine, garlic, and cinnamon in physically active people. Results: Capsaicin shows thermogenic effects and supports fat metabolism, boosting exercise performance, but GI effects need study. Turmeric, via curcumin, offers anti-inflammatory and antioxidant benefits, reducing muscle damage and speeding recovery despite low bioavailability. Ginger modulates cellular metabolism to aid muscle recovery and ease post-exercise pain. Piperine enhances nutrient bioavailability, improves muscle strength, and optimizes energy metabolism with low-risk toxicity. Garlic reduces oxidative stress and inflammation, strengthens immunity, and relieves muscle fatigue. Cinnamon provides hypoglycemic and antioxidant properties, improving glucose/lipid metabolism and cardiovascular health in athletes. Conclusions: These spices show promise as phytonutrients in sports medicine. Their anti-inflammatory, antioxidant, and metabolic effects enhance performance and recovery by increasing muscle strength, reducing DOMS, shortening recovery, and lowering inflammation. Synergies like piperine-curcumin amplify efficacy. Challenges like poor bioavailability (e.g., curcumin) and inconsistent evidence require rigorous studies for optimal dosages, formulations, and protocols.

2 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
AĆAleksandra Ćwirko-Godycka
Aleksandra Ćwirko-Godycka
NMNikola Murawska
Nikola Murawska
MCMichalina Chodór
Michalina Chodór
ATAleksandra Tomaszewska
Aleksandra Tomaszewska
KKKinga Karczewska
Kinga Karczewska
RFRyszard Feret
Ryszard Feret
Introduction and objective: Endocrine disorders affect the regulation of metabolic processes and are often associated with disturbances in glucose and hormonal homeostasis. In recent years, digital tools have increasingly contributed to the diagnosis and monitoring of metabolic diseases. Technological advancements have introduced continuous glucose monitoring (CGM) for patients with diabetes, as well as artificial intelligence (AI) algorithms to support the assessment of hormonal and imaging parameters in the diagnosis of PCOS. Despite these advances, studies on patients with diabetes using CGM who are simultaneously diagnosed with PCOS remain limited. AI-based diagnostic tools show promising accuracy in detecting PCOS characteristics through hormonal profiles and ultrasound imaging. The aim of this review is to summarize current evidence on CGM systems and AI in the evaluation and diagnosis of endocrine disorders, focusing on diabetes and PCOS. Methods: This narrative review analyzed literature from 2019–2025 and one earlier publication using PubMed and Google Scholar, focusing on CGM, AI, and diagnostic approaches in endocrine disorders. Results: CGM provides valuable insight into glucose variability and metabolic patterns in diabetes, but evidence for its use in patients with concurrent PCOS is limited. AI-based tools demonstrate high accuracy in identifying PCOS features, especially through hormonal profiling and ultrasound analysis. Conclusion: Digital technologies such as CGM and AI offer promising opportunities to improve the evaluation and management of endocrine disorders, particularly in women with PCOS. Larger, standardized studies are needed to validate clinical utility and support integration into routine care.

23 December 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MCMichalina Chodór
Michalina Chodór
MKMaciej Kokoszka
Maciej Kokoszka
ATAleksandra Tomaszewska
Aleksandra Tomaszewska
KKKinga Karczewska
Kinga Karczewska
SMSonia Mojzyk
Sonia Mojzyk
RFRyszard Feret
Ryszard Feret
Introduction: Breast cancer represents the most frequently diagnosed malignancy among women globally, affecting approximately 2.12 million new cases annually according to the Global Burden of Disease 2021 analysis. While radical mastectomy remains the primary surgical treatment, it often results in significant chest wall defects and axillary distortion with profound negative impacts on body image, psychological well-being, and overall quality of life (QoL). Breast reconstruction has evolved into an integral component of modern oncological treatment, extending beyond aesthetic considerations to encompass comprehensive patient-reported outcomes and functional recovery. Contemporary healthcare increasingly embraces precision medicine principles, wherein breast reconstruction serves as a paradigmatic field requiring personalized treatment algorithms that balance oncological safety, aesthetic outcomes, and patient-specific variables. This comprehensive review synthesizes current evidence on precision medicine approaches in breast reconstruction, examining surgical innovations, postoperative rehabilitation strategies, and patient-centered outcome assessment. Materials and Methods: This review constitutes a thorough analysis of peer-reviewed literature obtained from the PubMed scientific database, synthesizing materials spanning from the Introduction through References of the manuscript. The analysis encompasses recent advances in surgical techniques, rehabilitation protocols, bioengineered technologies, and patient-reported outcome measures employed in breast reconstruction following mastectomy. Key Findings: Contemporary breast reconstruction integrates three interdependent pillars: advanced surgical techniques, targeted postoperative rehabilitation, and precise patient-centered outcome assessment via validated tools such as BREAST-Q. Modern surgical strategies include nipple-sparing mastectomy (NSM) with immediate reconstruction, prepectoral breast reconstruction utilizing acellular dermal matrices (ADM), and autologous free flap techniques (particularly DIEP flaps). Enhanced Recovery After Surgery (ERAS) protocols significantly reduce hospitalization duration to post-operative day 3 with equivalent complication rates compared to traditional protocols. Early mobilization and structured physical therapy demonstrably improve shoulder range of motion and functional outcomes. Patient-reported outcomes consistently demonstrate that autologous reconstruction produces superior satisfaction and health-related quality of life compared to implant-based approaches. Emerging tissue engineering technologies, including three-dimensional bioprinting, adipose-derived stem cells, and bioengineered scaffolds, represent promising future directions for functional breast reconstruction with reduced morbidity. Conclusions: Precision medicine in breast reconstruction requires integrated decision-making incorporating molecular data, clinical variables, and subjective patient experiences throughout all treatment phases. Optimal outcomes depend upon personalized surgical strategy selection, early and targeted rehabilitation, and standardized measurement of patient-reported outcomes. This multifaceted, precision-based approach ensures maximal functional and psychological benefits while minimizing procedural morbidity, ultimately delivering comprehensive quality of life improvements for breast cancer survivors.

16 April 2026 in Health Problems of Civilization
Verified
Journal Article
Open access
JBJudyta Bordakiewicz
Judyta Bordakiewicz
DPDonata Pokorska
Donata Pokorska
MCMichalina Chodór
Michalina Chodór
MKMaciej Kokoszka
Maciej Kokoszka
ZMZuzanna Michalska
Zuzanna Michalska
MWMagdalena Wiciak
Magdalena Wiciak
Microplastics (MPs) have been detected in nearly all environmental compartments. The crucial routes of human exposure include the indoor environment, where the concentration of airborne fibers is higher than outdoors, the consumption of contaminated food, and contact with cookware, medical equipment, and personal care products made from or containing plastic. Depending on how MPs enter the body, through ingestion, inhalation, or dermal contact, they can reach a variety of organs. In this study, we focus on the detection of MPs and their consequences in several organs, which have not been sufficiently described in literature before, including the kidneys, placenta, testes, heart, brain, bone marrow, and in bodily secretions, namely semen and breast milk. To ensure the most accurate and up-to-date data, the presented results are based on papers published within the past three years. Experimental and clinical studies link exposure to MPs to oxidative stress, inflammation, dysbiosis, mitochondrial damage, fibrosis, and potential carcinogenic and neurotoxic effects. These mechanisms, occurring in the aforementioned tissues, raise concerns regarding fertility, fetal development, metabolic health, and neurodegeneration. However, further improvements in detection of MPs and contamination prevention methods are needed to minimize the potential health risks associated with exposure.

26 May 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
ZMZuzanna Michalska
Zuzanna Michalska
JKJulia Maria Kuczkowska
Julia Maria Kuczkowska
JBJudyta Bordakiewicz
Judyta Bordakiewicz
MCMichalina Chodór
Michalina Chodór
MKMaciej Kokoszka
Maciej Kokoszka
MWMagdalena Wiciak
Magdalena Wiciak
Objective: The aim of this narrative review was to summarize the current state of knowledge regarding the role of the gut microbiome in the pathogenesis of Hashimoto’s disease and to discuss potential microbiome-targeted therapeutic strategies. Methods: A narrative literature review was conducted using publications indexed in the PubMed, Google Scholar and Scopus databases. Original research articles, systematic reviews, and meta-analyses focusing on Hashimoto’s disease and gut microbiota interactions were included. Most studies were selected from the past 10-15 years, with approximately 80% of the included literature published within the last five years (2021–2025), ensuring up-to-date evidence. Key findings: Available evidence indicates that patients with Hashimoto’s disease exhibit gut dysbiosis characterized by reduced microbial diversity, decreased abundance of short-chain fatty acid-producing bacteria, and an overrepresentation of potentially pathogenic microorganisms. These alterations are associated with impaired intestinal barrier integrity, increased systemic inflammation, and dysregulation of immune responses, particularly an imbalance between regulatory T cells and Th17 lymphocytes. Furthermore, microbiome disturbances may contribute to thyroid autoimmunity through mechanisms such as molecular mimicry and translocation of bacterial antigens. Emerging studies suggest that dietary modification, probiotic and synbiotic supplementation, and fecal microbiota transplantation may positively influence thyroid function and immune regulation. Conclusions: Although levothyroxine replacement remains the standard treatment for Hashimoto’s disease, modulation of the gut microbiome represents a promising adjunctive therapeutic approach. Further well-designed clinical trials are required to clarify causal relationships and evaluate the efficacy of microbiome-targeted interventions in autoimmune thyroid disease.